Orchard Therapeutics - U.S. Alternatives & Competitors
12 companies similar to Orchard Therapeutics - U.S. — Dedicated to transforming the lives of patients with severe and other genetic di...
Genespire
Biotechnology company focused on developing transformative gene therapies for patients aff...
Milan, Italy
Jazz Pharmaceuticals
Identifying, developing and commercializing meaningful products that address unmet medical...
Dublin, Ireland
Entrada Therapeutics
Innovating to transform the treatment of serious diseases through establishing a new class...
Boston, United States
Ascidian Therapeutics
Rewriting RNA
Boston, United States
Track all Orchard Therapeutics - U.S. competitors
Get real-time alerts when any of these companies raise funding, hire, or show growth signals.
bluebird bio
Pursuing curative gene therapies to give patients and their families more bluebird days.
Somerville, United States
AskBio Inc.
Pioneering science to create transformative molecular medicines.
United States
PepGen
Better Technology. Better Delivery. Developing a new generation of disease-modifying thera...
Boston, United States
BioMarin Pharmaceutical Inc.
We transform lives through genetic discovery.
San Rafael, United States
Prevail Therapeutics
Wholly owned subsidiary of Eli Lilly and Company
New York, United States
Rocket Pharmaceuticals
Seeking gene therapy cures
Cranbury, United States
Intellia Therapeutics, Inc.
Developing curative genome editing treatments
Cambridge, United States
Gene2info
Enhancing human life through innovation
Istanbul, Turkey
About Orchard Therapeutics - U.S.
Dedicated to transforming the lives of patients with severe and other genetic diseases through innovative gene therapy.
Development of HSC Gene Therapy, Research and Application of Gene Therapy in Genetic Diseases, Patient-centric Therapeutic Solutions
Families with Members Affected by Genetic Diseases, Healthcare Professionals, Medical Institutions, Researchers in Medical and Genetic Fields
Gene Therapy, Hematopoietic Stem Cell Therapy, Autologous Ex Vivo Therapy, Rare Genetic Diseases, Severe Diseases, Strimvelis, Metachromatic Leukodystrophy, Wiskott-Aldrich Syndrome, Adenosine Deaminase Severe Combined Immunodeficiency, X-linked Chronic Granulomatous Disease, Beta-thalassemia, Clinical Research, Commercial-stage Biotech, Partnerships With Academic Institutions, Curative Treatments
B2B, B2C, B2D
Product Sales, Service Fee, Value Based Pricing
Frequently Asked Questions
Don't just read about them. Follow them.
BounceWatch watches Orchard Therapeutics - U.S. and millions of other companies. When one raises money, hires quickly or changes its product, we tell you the same day.
Compiled from the BounceWatch company index. We last looked at Orchard Therapeutics - U.S. on 11 Mar 2026. The 12 companies listed here were last checked between 9 Jun 2026 and 7 Sep 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.